beta

AEZS

Æterna Zentaris, Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Market Cap: 10.4 Million

Primary Exchange: NASDAQ

Website: http://www.zentaris.com

Shares Outstanding: 23.5 Million

Float: 23.5 Million

Dividend: (%)

Beta: 1.06249513635972

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1894 trading days

From: 2013-01-29 To: 2020-07-10

Lowest Point:

Microcaps mostly among midday movers

via: SeekingAlpha at 2019-06-13 08:41:38:000

Gainers: Coda Octopus Group (NASDAQ: CODA ) +40% . Mmtec (NASDAQ: MTC ) +30% . Red Robin Gourmet Burgers (NASDAQ: RRGB ) +29% . DryShips (NASDAQ: DRYS ) +24% . Cemtrex (NASDAQ: CETX ) +21% . Ruhnn Holding Limited (NASDAQ: RUHN ) +21% . RH (NYSE: RH ) +20% . Aeterna Zentaris (N… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2015-11-20 100.0 1.0 100.0
Data provided by IEX Cloud